Papaverine is a nonxanthine phosphodiesterase inhibitor for the relief of cerebral and peripheral ischemia associated with arterial spasm and myocardial ischemia complicated by arrhythmias. The main actions of Papaverine are exerted on cardiac and smooth muscle. Like qathidine, Papaverine acts directly on the heart muscle to depress conduction and prolong the refractory period. Papaverine relaxes various smooth muscles.
This report contains market size and forecasts of Papaverine Hydrochloride Injection in global, including the following market information:
Global Papaverine Hydrochloride Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Papaverine Hydrochloride Injection Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Papaverine Hydrochloride Injection companies in 2021 (%)
The global Papaverine Hydrochloride Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30 mg/mL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Papaverine Hydrochloride Injection include Sandoz, American Regent, Jiangsu Hengrui Medicine and Chengdu Brilliant Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Papaverine Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Papaverine Hydrochloride Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Papaverine Hydrochloride Injection Market Segment Percentages, by Type, 2021 (%)
30 mg/mL
120 mg/10 mL
Global Papaverine Hydrochloride Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Papaverine Hydrochloride Injection Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Papaverine Hydrochloride Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Papaverine Hydrochloride Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Papaverine Hydrochloride Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Papaverine Hydrochloride Injection revenues share in global market, 2021 (%)
Key companies Papaverine Hydrochloride Injection sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Papaverine Hydrochloride Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz
American Regent
Jiangsu Hengrui Medicine
Chengdu Brilliant Pharmaceutical Group